Literature DB >> 11245713

Cognitive status and quality of life in patients with suspected versus proven low-grade gliomas.

J C Reijneveld1, M M Sitskoorn, M Klein, J Nuyen, M J Taphoorn.   

Abstract

BACKGROUND: The preferred management of patients with suspected low-grade gliomas (S-LGG) remains controversial. The benefits of resection or radiotherapy early in the course of the disease have not been proven in terms of survival. Little is known about the effects of early therapy on quality of life (QOL) and cognitive status. The authors compared functional status, QOL, and cognitive status of patients suspected of having a LGG, in whom treatment was deferred, and patients with proven LGG (P-LGG), who underwent early surgery.
METHODS: The authors recruited 24 patients suspected of having an LGG. These patients were matched with 24 patients with a histologically proven LGG and healthy control subjects for educational level, handedness, age, and gender. The two patient groups were also matched for tumor laterality, use of anticonvulsants, and interval between diagnosis and testing. Functional status was determined in both patient groups. QOL and cognitive status were compared between the three groups.
RESULTS: Matching criteria and functional status did not differ significantly between groups. Both patient groups scored worse on QOL scales than healthy control subjects. Unoperated patients with S-LGG scored better on most items than patients with P-LGG. Cognitive status was worse in both groups than in healthy control subjects, but, again, patients with S-LGG performed better than patients with P-LGG.
CONCLUSION: These data suggest that a wait-and-see policy in patients with S-LGG has no negative effect on cognitive performance and QOL.

Entities:  

Mesh:

Year:  2001        PMID: 11245713     DOI: 10.1212/wnl.56.5.618

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  39 in total

Review 1.  Review on quality of life issues in patients with primary brain tumors.

Authors:  Martin J B Taphoorn; Eefje M Sizoo; Andrew Bottomley
Journal:  Oncologist       Date:  2010-05-27

2.  The relationship between function, quality of life and coping in patients with low-grade gliomas.

Authors:  Margareta Gustafsson; Tanja Edvardsson; Gerd Ahlström
Journal:  Support Care Cancer       Date:  2006-05-19       Impact factor: 3.603

Review 3.  Late effects of cancer treatment: consequences for long-term brain cancer survivors.

Authors:  Montse Alemany; Roser Velasco; Marta Simó; Jordi Bruna
Journal:  Neurooncol Pract       Date:  2020-07-16

Review 4.  Contemporary surgical outcome for skull base meningiomas.

Authors:  Chien-Min Chen; Abel Po-Hao Huang; Lu-Ting Kuo; Yong-Kwang Tu
Journal:  Neurosurg Rev       Date:  2011-05-26       Impact factor: 3.042

5.  Proton MRS imaging in the follow-up of patients with suspected low-grade gliomas.

Authors:  J C Reijneveld; J van der Grond; L M P Ramos; J E C Bromberg; M J B Taphoorn
Journal:  Neuroradiology       Date:  2005-08-20       Impact factor: 2.804

6.  Pitfalls in the assessment of disability in individuals with low-grade gliomas.

Authors:  Anneli Påhlson; Lena Ek; Gerd Ahlström; Anja Smits
Journal:  J Neurooncol       Date:  2003-11       Impact factor: 4.130

Review 7.  Neurocognitive functioning in adult WHO grade II gliomas: impact of old and new treatment modalities.

Authors:  Martin Klein
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

Review 8.  Reporting of patient-reported health-related quality of life in adults with diffuse low-grade glioma: a systematic review.

Authors:  Daniel M Fountain; Dominic Allen; Alexis J Joannides; Dipankar Nandi; Thomas Santarius; Aswin Chari
Journal:  Neuro Oncol       Date:  2016-05-18       Impact factor: 12.300

9.  Low-grade gliomas in older patients: long-term follow-up from Mayo Clinic.

Authors:  David A Schomas; Nadia N Laack; Paul D Brown
Journal:  Cancer       Date:  2009-09-01       Impact factor: 6.860

Review 10.  A critical review of the clinical effects of therapeutic irradiation damage to the brain: the roots of controversy.

Authors:  Carol L Armstrong; Kunsang Gyato; Abdel W Awadalla; Robert Lustig; Zelig A Tochner
Journal:  Neuropsychol Rev       Date:  2004-03       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.